A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes similar to the current standard of care, a clinical trial co-led by a UT Southwestern Medical Center researcher shows. The findings, published in the Journal of Clinical Oncology, could lead to new treatment regimens that are significantly safer and less detrimental to patients’ quality of life.